Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: Possible role for aprotinin

Transfusion

Volumn 48, Issue SUPPL. 1, 2008, Pages

  Poston, Robert S ^a,b   Gu, Junyan ^b   White, Charles ^b   Jeudy, Jean ^b   Nie, Lei ^b   Brown, James ^b   Gammie, James ^b   Pierson, Richard N ^b   Romar, Linda ^b   Griffith, Bartley P ^b  

^a Division of Cardiac Surgery   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; HEPARIN; PROTAMINE; THROMBIN; THROMBOPLASTIN;

AORTA; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY SINUS; ENDOTHELIUM; GRAFT FAILURE; GRAFT PATENCY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

APROTININ; ASPIRIN; BLOOD COAGULATION; COHORT STUDIES; CORONARY ARTERY BYPASS, OFF-PUMP; DRUG RESISTANCE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMOSTATICS; HUMANS; PERIOPERATIVE CARE; PLATELET ACTIVATION; THROMBOPLASTIN;

EID: 43149100128     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01575.x     Document Type: Conference Paper

References (28)

1. Dixon B, Santamaria J, Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005 128 : 229 36.
2. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, Smith KJ. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993 82 : 3350 7.
3. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001 72 : S1821 31.
4. Pothula A, Serebruany VL, Gurbel PA, McKenzie ME, Atar D. Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease. Eur J Pharmacol 2000 402 : 1 10.
5. Poston RS, Gu J, White C, Brown J, Gammie J, Pierson RN, Lee A, Connerney I, Avari T, Christenson R, Tandry U, Griffith BP. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Ann Thorac Surg 2006 81 : 104 10.
6. Poston RS, White C, Gu J, Read K, Gammie J, Brown J, Lee A, Griffith B, Pierson R III. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006 131 : 22 30.
7. Day JR, Punjabi PP, Randi AM, Haskard DO, Landis RC, Taylor KM. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 2004 110 : 2597 600.
8. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis RC. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 2000 120 : 370 8.
9. Manchio JV, Gu J, Romar L, Brown J, Gammie J, Pierson RN, Griffith B, Poston RS. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. Ann Thorac Surg 2005 79 : 1991 8.
10. Poston R, Gu J, Manchio J, Lee A, Brown J, Gammie J, White C, Griffith BP. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 2005 27 : 584 91.
11. Muluk SC, Vorp DA, Severyn DA, Gleixner S, Johnson PC, Webster MW. Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamics. J Vasc Surg 1998 27 : 521 7.
12. Kalweit G, Bach J, Huwer H, Winning J, Hellstern P. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood. Thromb Res 2005 116 : 33 9.
13. Frazier AA, Qureshi F, Read KM, Gilkeson RG, Poston RS, White CS. Coronary artery bypass grafts: assessment with multidetector CT in the early and late postoperative setting. Radiographics 2005 25 : 881 96.
14. Poston RS, White C, Gu J, Brown J, Gammie J, Pierson RN, Lee A, Connerney I, Avari T, Christenson R, Tandry U, Griffith BP. Safety and efficacy of aprotinin in off-pump coronary artery bypass grafting (OPCAB): a double-blind, placebo-controlled randomized trial. Circulation 2004 110 : III 546.
15. Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Berrios E, Green C, Krucoff M, Harrington RA, Ohman EM, Califf RM. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995 91 : 1929 35.
16. Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin? J Cardiovasc Pharmacol 1996 27 Suppl 1 : S50 7.
17. Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology 1995 83 : 679 89.
18. Mariani MA, Gu Y, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 1999 67 : 1370 5.
19. Hoffmann H, Siebeck M, Thetter O, Jochum M, Fritz H. Effect of aprotinin and C1-esterase inhibitor on activation of the plasma kallikrein-kinin system in vivo. Prog Clin Biol Res 1987 236A : 159 64.
20. Khan MM, Gikakis N, Miyamoto S, Rao AK, Cooper SL, Edmunds LH Jr, Colman RW. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass. Ann Thorac Surg 1999 68 : 473 8.
21. Chabbat J, Porte P, Tellier M, Steinbuch M. Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex. Thromb Res 1993 71 : 205 15.
22. Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001 88 : 230 5.
23. Vanschoonbeek K, Feijge MA, Van Kampen RJ, Kenis H, Hemker HC, Giesen PL, Heemskerk JW. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004 2 : 476 84.
24. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998 116 : 716 30.
25. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004 128 : 442 8.
26. Moller CH, Steinbruchel DA. Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? Scand Cardiovasc J 2003 37 : 149 53.
27. Poston RS, White C, Read K, Griffith B. Quantifying neointimal hyperplasia in aortocoronary saphenous vein bypass grafts using multichannel CT angiography [abstract]. J Am Coll Surg 2005 201 : S25 6.
28. Landis RC, Asimakopoulos G, Poullis M, Haskard DO, Taylor KM. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 2001 72 : 2169 75.